Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-10 Sale |
2023-02-10 4:42 pm |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
11,643 | $44.61 | $519,413 | 121,981 (Direct) |
View |
| 2022-11-10 Purchase |
2022-11-15 4:04 pm |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
14,500 | $34.48 | $500,022 | 46,940 (Direct) |
View |
| 2022-05-05 Purchase |
2022-05-09 09:32 am |
Sage Therapeutics Inc. | SAGE | Golumbeski George Director |
8,000 | $31.45 | $251,563 | 8,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-13 Option Award |
2023-02-15 4:47 pm |
N/A 2033-02-13 |
Sage Therapeutics Inc. | SAGE | Gault Laura Chief Medical Officer |
2,660 | $0 | 2,660 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:47 pm |
N/A 2033-02-13 |
Sage Therapeutics Inc. | SAGE | Cook Anne Marie SVP, GC & Secretary |
19,000 | $0 | 19,000 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:47 pm |
N/A 2033-02-13 |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
16,720 | $0 | 16,720 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:46 pm |
N/A 2033-02-13 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:46 pm |
N/A 2033-02-13 |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
66,500 | $0 | 66,500 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:46 pm |
N/A 2033-02-13 |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
16,720 | $0 | 16,720 (Direct) |
View |
| 2023-02-10 Exercise |
2023-02-10 4:42 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
11,643 | $0.45 | 121,981 (Direct) |
View |
| 2023-02-10 Exercise |
2023-02-10 4:42 pm |
N/A 2023-08-12 |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
11,643 | $0 | 121,981 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
5,100 | $0 | 121,981 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
1,427 | $44.16 | 121,981 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
3,375 | $0 | 145,553 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
1,127 | $44.16 | 145,553 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
2,850 | $0 | 61,560 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
914 | $44.16 | 61,560 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Cook Anne Marie SVP, GC & Secretary |
2,850 | $0 | 10,498 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Cook Anne Marie SVP, GC & Secretary |
980 | $44.16 | 10,498 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
6,750 | $0 | 5,260 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
2,119 | $44.16 | 5,260 (Direct) |
View |
| 2023-01-09 Exercise |
2023-01-11 4:02 pm |
N/A 2024-01-22 |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
1,600 | $0 | 65,266 (Direct) |
View |
| 2023-01-09 Exercise |
2023-01-11 4:02 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
1,600 | $1.36 | 65,266 (Direct) |
View |
| 2023-01-04 Exercise |
2023-01-05 4:30 pm |
N/A 2024-01-22 |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
1,800 | $0 | 65,266 (Direct) |
View |
| 2023-01-04 Exercise |
2023-01-05 4:30 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
1,800 | $1.36 | 65,266 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 4:30 pm |
N/A 2033-01-04 |
Sage Therapeutics Inc. | SAGE | PAUL STEVEN M Director |
2,395 | $0 | 2,395 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 4:29 pm |
N/A 2033-01-04 |
Sage Therapeutics Inc. | SAGE | Golumbeski George Director |
2,108 | $0 | 2,108 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 4:29 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
2,501 | $28.63 | 175,807 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 4:29 pm |
N/A 2026-02-08 |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
2,501 | $0 | 175,807 (Direct) |
View |
| 2022-11-28 Other |
2022-11-30 4:15 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | PAUL STEVEN M Director |
5 | $38.17 | 593,116 (Indirect) |
View |
| 2022-11-01 Option Award |
2022-11-01 5:30 pm |
N/A 2032-11-01 |
Sage Therapeutics Inc. | SAGE | Gault Laura Chief Medical Officer |
64,410 | $0 | 64,410 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:02 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer |
9,500 | $0 | 9,500 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 4:36 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director |
9,947 | $0 | 9,947 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 4:36 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | COLA MICHAEL F Director |
9,947 | $0 | 9,947 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 4:35 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | Golumbeski George Director |
9,947 | $0 | 9,947 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 4:35 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | Barrett Elizabeth Director |
9,947 | $0 | 9,947 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 4:35 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | Germano Geno J Director |
9,947 | $0 | 9,947 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 4:35 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | PAUL STEVEN M Director |
9,947 | $0 | 9,947 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 4:35 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | STARR KEVIN P Director |
9,947 | $0 | 9,947 (Direct) |
View |
| 2022-04-27 Exercise |
2022-04-29 08:40 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
30,944 | $0.45 | 127,450 (Direct) |
View |
| 2022-04-27 Exercise |
2022-04-29 08:40 am |
N/A 2023-08-12 |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director |
30,944 | $0 | 127,450 (Direct) |
View |
| 2022-02-17 Exercise |
2022-02-18 4:10 pm |
N/A 2024-01-22 |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
4,500 | $0 | 64,642 (Direct) |
View |
| 2022-02-17 Exercise |
2022-02-18 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
4,500 | $1.36 | 64,642 (Direct) |
View |
| 2022-02-17 Exercise |
2022-02-18 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer |
4,000 | $0.45 | 127,450 (Direct) |
View |
| 2022-02-17 Exercise |
2022-02-18 4:10 pm |
N/A 2023-08-12 |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer |
4,000 | $0 | 127,450 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:43 pm |
N/A 2032-02-11 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer |
11,400 | $0 | 11,400 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:42 pm |
N/A 2032-02-11 |
Sage Therapeutics Inc. | SAGE | Greene Barry E President and CEO |
69,920 | $0 | 69,920 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:42 pm |
N/A 2032-02-11 |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
13,300 | $0 | 13,300 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:42 pm |
N/A 2032-02-11 |
Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO & Treasurer |
15,200 | $0 | 15,200 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:41 pm |
N/A 2032-02-11 |
Sage Therapeutics Inc. | SAGE | Cook Anne Marie SVP, GC & Secretary |
15,200 | $0 | 15,200 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:41 pm |
N/A 2032-02-11 |
Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer |
15,200 | $0 | 15,200 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 4:08 pm |
N/A 2032-01-04 |
Sage Therapeutics Inc. | SAGE | PAUL STEVEN M Director |
1,638 | $0 | 1,638 (Direct) |
View |